Acadia Pharmaceuticals ACAD Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $391M+72.7% | $226.45M+469% | -$61.29M+71.6% | -$215.98M-28.7% | ||
| $871K-5.3% | $920K-36.9% | $1.46M-28.0% | $2.03M-9.4% | ||
| $52.14M-22.2% | $67.05M+0.9% | $66.42M-2.6% | $68.2M+7.2% | ||
| —— | $157.72M+844% | $16.7M+115% | -$114.04M+9.3% | ||
| $4.69M— | —— | $50K— | $0-100% | ||
| -$302.56M— | —— | $32.35M— | —— | ||
| $49.88M+629% | $6.85M-72.8% | $25.13M+206% | $8.2M-54.9% | ||
| —— | $133.93M+81.5% | $73.81M+326% | -$32.59M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Acadia Pharmaceuticals generate?
- Acadia Pharmaceuticals (ACAD) generated $192.5M in operating cash flow over the trailing twelve months.
- What is Acadia Pharmaceuticals's free cash flow?
- After $9.9M of capital expenditures, Acadia Pharmaceuticals's free cash flow was $186.7M over the trailing twelve months, up 13.4% year over year.
- Where does Acadia Pharmaceuticals's cash flow data come from?
- Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
